Clinical and Developmental Immunology · 2012 · 13 citations · 19 references
Life SciencesImmunologyInfectious DiseasesApoptosisImmunology Of Infectious DiseasesImmunoregulationCell-mediated ImmunityCytotoxic T Lymphocyte ResponsesDendritic Cell BiologyDendritic Cell RegulationT Cell ActivationT Cell BiologyCell Division ControlDendritic Cell ApoptosisDendritic Cell Tolerogenic FunctionDendritic Cell TolerogenicityImmune FailureImmune Tolerance FailureMixed Lymphocyte ReactionTolerogenic Dendritic Cells
The PD-1/B7-H1-mediated induction of T cell apoptosis/anergy as a possible mechanism of immune response failure was studied in 76 patients with pulmonary tuberculosis (TB) with normal and low-proliferative response to antigens of M. tuberculosis (purified protein derivative (PPD)). It was revealed that dendritic cells (DCs), generated in vitro from patient blood monocytes with GM-CSF + IFN-α, were characterized by increased B7-H1 expression, upproduction of IL-10, and reducing of allostimulatory activity in mixed lymphocyte culture (MLC). Moreover, DCs of patients with TB were able to enhance T cell apoptosis and to block T-cell division in MLC. It was shown that neutralizing anti-PD1 antibodies significantly decreased the proapoptogenic/tolerogenic effect of DCs. Correlation analysis revealed a direct relationship between IL-10 production and level of B7-H1 expression in the general group of investigated patients. It was demonstrated that generation of healthy donor DCs in the presence of IL-10 led to an increase in the number of DCs-expressed B7-H1 molecule, DC proapoptogenic activity, and a decrease in their allostimulatory activity. Obviously, the revealed phenomenon of the PD-1/B7-H1-mediated pro-apoptogenic activity of DCs is clinically significant since the cytotoxic/tolerogenic potential of DCs is more pronounced in patients with PPD anergy.
19
Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity
Tyler J. Curiel, Shuang Wei, Haidong Dong et al. · Nature Medicine · 2003 · 1.3K citations
Life Sciences, Immunology, Oncology +15
Bettina Schreiner, Meike Mitsdoerffer, Bernd C. Kieseier et al. · Journal of Neuroimmunology · 2004 · 269 citations
Life Sciences, Immunology, Neurology +17